✦ LIBER ✦

10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial

✍ Scribed by J. Douillard; S. Siena; J. Cassidy; J. Tabernero; R. Burkes; M.E. Barugel; Y. Humblet; D. Cunningham; M. Wolf; J.L. Gansert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6095 POSTER Randomized, Open-label, Phas

✍ Burkes, R.; Siena, S.; Cassidy, J.; Tabernero, J.; Barugel, M.E.; Humblet, Y.; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Final results from PRIME: randomized pha

✍ Douillard, J. Y.; Siena, S.; Cassidy, J.; Tabernero, J.; Burkes, R.; Barugel, M. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 576 KB

14LBA Randomized phase 3 study of panitu

✍ M. Peeters; T. Price; Y. Hotko; A. Cervantes; M. Ducreux; T. André; E. Chan; F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A Phase 2b, Double-Blind, Randomized Stu

✍ J. Tabernero; R. Garcia-Carbonero; C.H. Könne; P.J. O'Dwyer; A. Sobrero; E. Van 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB